Cargando…

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1

Nitro-substituted 1,3-benzothiazinones (nitro-BTZs) are mechanism-based covalent inhibitors of Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose-2′-oxidase (DprE1) with strong antimycobacterial properties. We prepared a number of oxidized and reduced forms of nitro-BTZs to probe the mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Adrian, Rudolph, Ines, Möllmann, Ute, Voigt, Kerstin, Chung, Chun-wa, Singh, Onkar M. P., Rees, Michael, Mendoza-Losana, Alfonso, Bates, Robert, Ballell, Lluís, Batt, Sarah, Veerapen, Natacha, Fütterer, Klaus, Besra, Gurdyal, Imming, Peter, Argyrou, Argyrides
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128881/ https://www.ncbi.nlm.nih.gov/pubmed/30194385 http://dx.doi.org/10.1038/s41598-018-31316-6

Ejemplares similares

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
por: Batt, Sarah M., et al.
Publicado: (2023)

Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
por: Wang, Pengxu, et al.
Publicado: (2021)

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2018)

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
por: Chhabra, Sonali, et al.
Publicado: (2021)

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023)

Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014)

Acceptor Substrate Discrimination in Phosphatidyl-myo-inositol Mannoside Synthesis: STRUCTURAL AND MUTATIONAL ANALYSIS OF MANNOSYLTRANSFERASE CORYNEBACTERIUM GLUTAMICUM PimB′
por: Batt, Sarah M., et al.
Publicado: (2010)

Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
por: Yadav, Veena D., et al.
Publicado: (2023)

Benzothiazinones Mediate Killing of Corynebacterineae by Blocking Decaprenyl Phosphate Recycling Involved in Cell Wall Biosynthesis
por: Grover, Shipra, et al.
Publicado: (2014)

Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools
por: Mali, Suraj N., et al.
Publicado: (2022)

Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
por: Richter, Adrian, et al.
Publicado: (2021)

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
por: Ramey, Michelle E., et al.
Publicado: (2023)

Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones
por: Madikizela, Balungile, et al.
Publicado: (2021)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
por: Veerapen, Natacha, et al.
Publicado: (2011)

Calreticulin Controls the Rate of Assembly of CD1d Molecules in the Endoplasmic Reticulum
por: Zhu, Yajuan, et al.
Publicado: (2010)

Synthesis and biological activity of α-l-fucosyl ceramides, analogues of the potent agonist, α-d-galactosyl ceramide KRN7000
por: Veerapen, Natacha, et al.
Publicado: (2010)

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
por: Robertson, Gregory T., et al.
Publicado: (2021)

Disruption of Mycobacterial AftB Results in Complete Loss of Terminal β(1 → 2) Arabinofuranose Residues of Lipoarabinomannan
por: Jankute, Monika, et al.
Publicado: (2016)

Synthesis and biological activity of α-glucosyl C24:0 and C20:2 ceramides
por: Jervis, Peter J., et al.
Publicado: (2010)

Endoplasmic Reticulum Glycoprotein Quality Control Regulates CD1d Assembly and CD1d-mediated Antigen Presentation
por: Kunte, Amit, et al.
Publicado: (2013)

Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Crystallographic evidence for unintended benzisothiazolinone 1-oxide formation from benzothiazinones through oxidation
por: Eckhardt, Tamira, et al.
Publicado: (2020)

2-Chloro-3-nitro-5-(trifluoromethyl)benzoic acid and -benzamide: structural characterization of two precursors for antitubercular benzothiazinones
por: Richter, Adrian, et al.
Publicado: (2021)

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis
por: de Jesus Lopes Ribeiro, Ana Luisa, et al.
Publicado: (2011)

Effects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope
por: Meyer, Fabian M., et al.
Publicado: (2023)

Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009)

Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone
por: Muppidi, Jagan R., et al.
Publicado: (2011)

Structural and functional analysis of the solute-binding protein UspC from Mycobacterium tuberculosis that is specific for amino sugars
por: Fullam, Elizabeth, et al.
Publicado: (2016)

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
por: Fan, Dongguang, et al.
Publicado: (2023)

The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system
por: Batt, Sarah M., et al.
Publicado: (2020)

A humanized mouse model for in vivo evaluation of invariant Natural Killer T cell responses
por: Saavedra-Avila, Noemi Alejandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r5rtpt4390srhi4c4rt0i6ggo0